Abstract
Human papillomavirus or HPV are oncogenic viruses involved in many cancers. It is estimated that around 5% of cancers worldwide are linked to HPV infection. Cancers of the cervix, vagina, vulva, anus, penis and throat (tonsil) are virally induced in proportions ranging from 35 to almost 100%. These cancers are not all easily detected and the detection of lesions is not always simple and effective. Prophylactic anti-HPV vaccination is recognized for its effectiveness in the prevention of cervical cancers, its place in the prevention of other induced HPV cancers remains debated.
| Translated title of the contribution | VACCINATION AGAINST PAPILLOMAVIRUS: OUTSTANDING ISSUES |
|---|---|
| Original language | French |
| Pages (from-to) | 104-108 |
| Number of pages | 5 |
| Journal | Revue du Praticien |
| Volume | 70 |
| Issue number | 1 |
| Publication status | Published - 1 Jan 2020 |
| Externally published | Yes |